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Background: Plant-derived compounds have been used clinically to treat type 2 diabetes for many years as they
also exert additional beneficial effects on various other disorders. The aim of the present study was to investigate
the possible mechanism of anti-diabetic activity of twelve (seven Australian Aboriginal and five Indian Ayurvedic)
plant extracts.
Methods: The ethanolic plant extracts were investigated for glucose uptake and adipogenesis in murine 3T3-L1
adipocytes. Cytotoxicity studies were also carried out against two cancerous cell lines, HeLa and A549, to investigate
the potential anti-cancer activities of the extracts.
Results: Of the seven Australian Aboriginal plant extracts tested, only Acacia kempeana and Santalum spicatum
stimulated glucose uptake in adipocytes. Among the five Indian Ayurvedic plant extracts, only Curculigo orchioides
enhanced glucose uptake. With respect to adipogenesis, the Australian plants Acacia tetragonophylla, Beyeria
leshnaultii and Euphorbia drumondii and the Indian plants Pterocarpus marsupium, Andrographis paniculata and
Curculigo orchioides reduced lipid accumulation in differentiated adipocytes. Extracts of Acacia kempeana and Acacia
tetragonophylla showed potent and specific activity against HeLa cells.
Conclusions: The findings suggest that the plant extracts exert their anti-diabetic properties by different mechanisms,
including the stimulation of glucose uptake in adipocytes, inhibition of adipogenesis or both. Apart from their
anti-diabetic activities, some of the extracts have potential for the development of chemotherapeutic agents for the
treatment of cervical cancer.
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Type 2 diabetes has become a major health problem in
both developed and developing countries. The activities
of numerous plants have been evaluated and confirmed
in animal models which suggest that herbal remedies
could represent culturally relevant complementary and
alternative treatments, as well as serve in the search for
new anti-diabetic agents [1]. Readily-available high cal-
orie foods and sedentary lifestyles are major factors for
obesity which contribute to insulin resistance and type 2
diabetes. Insulin resistance is defined as defective insulin* Correspondence: vgulati@swin.edu.au
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unless otherwise stated.signalling and decreased insulin efficiency to induce
glucose transport from the blood into key target cells.
Obesity, mainly visceral fat, contributes to insulin resist-
ance [2]. Most anti-diabetic drugs promote long-term
weight gain [3]. Thus, these drugs treat one of the key
symptoms, hyperglycemia, but exacerbate weight gain and
obesity which further contribute to the progression of type
2 diabetes. Therefore, while these drugs are beneficial over
the short-term, they are not optimal for the long-term
health of type 2 diabetic patients [4]. The most desirable
situation would be the development of new types of anti-
diabetic drugs that are either hypoglycaemic or anti-
hyperglycemic without the side effect of promoting weight
gain [2]. Reducing obesity can slow down the rate of occur-
rence of type 2 diabetes [5]. Therefore, it is highly desirablehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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take by adipose or muscle cells but, unlike thiazolidine-
dione or insulin, do not induce obesity or other side effects
[6]. The increase in adipocyte lipid content can influence
adipocyte function by reducing adiponectin secretion
which promotes adipocyte differentiation, insulin sensi-
tivity and lipid accumulation in vivo [7]. Low levels of
circulating adiponectin have been linked to insulin re-
sistance and an increased risk of diabetes. Secondary
plant metabolites such as saponin glycosides, triter-
penes and phenolic compounds have been reported to
influence adipocyte differentiation in cultured 3T3-L1
cells, a murine fibroblast cell line that is often used as a
model for adipocyte metabolism [8].
Green et al. [9] established several cloned lines of
mouse 3T3 fibroblasts which are capable of differentiat-
ing into adipocyte-like cells in vitro. The most frequently
employed adipocyte cell lines, 3T3-F442A and 3T3-L1,
were clonally isolated from Swiss 3T3 cells derived from
disaggregated 17 to 19-day mouse embryos. Cell lines
have been used as model systems to understand various
mechanisms of plants in animal and human health as
they provide a continuous source of large numbers of
cells necessary for proliferation and differentiation. The
3T3-L1 cell line was selected for this study because it
displays relevant features including lipid storage and
glucose homeostasis. During differentiation, 3T3-L1 pre-
adipocytes become adipocytes with a 20-fold increase in
the number of insulin receptors and acquire the ability to
utilize glucose in response to insulin [10].
Many studies have exploited the Sprague–Dawley rat
model (SD model) for in vitro evaluation of hypoglycemic
activity. This is normally time-consuming, restricted to
limited animal sources and involves sacrificing of animals.
Therefore, the differentiated 3T3-L1 adipocyte model (3T3-
L1 model) was developed as an alternative to the SD model
and is used by researchers to evaluate hypoglycaemic and
anti-adipogenic effects and establish the mechanisms of
action. Wu et al. (2011) screened yeast extracts for
hypoglycemic activity with the 3T3-L1 model, compared
results with the SD model and found that the two models
were highly correlated [11].
Several studies have indicated that majority of diabetic
patients are obese or overweight and have higher risk of
developing cancers, thus showing the association of
diabetes and overall cancer incidence [12]. Cannata et al.
(2010) explained hyperinsulinaemia as the mechanism
linking diabetes and cancer. Insulin resistance in diabetic
patients may lead to cancer by directly affecting the can-
cer cells via overexpression of insulin-like growth factor
1(IGF1) and insulin receptor (IR) substrate proteins [13].
The American and European Diabetes and Oncology as-
sociations published a consensus report on diabetes and
cancer and agreed that most observational evidencesuggests a strong link between diabetes and breast,
colorectal, endometrial, liver and pancreatic cancers. The
pathogenesis of the link is due to hyperinsulinaemia, hyper-
glycaemia, adipocytokines, growth factors, inflammation
and possibly diabetes therapies [14]. Plants are rich source
of phytochemicals such as carotenoids, resveratrol, quer-
cetin, silymarin, sulphoraphane, and indole-3-carbino that
protect from chronic diseases and usually target multiple
cell signalling pathways [15]. Thus, we decided to explore
whether Australian Aboriginal and Indian Ayurvedic plants
can be utilised in the management of diabetes and related
complications.
In the search for novel treatments, attention should
be given to the many traditional herbal medicines for
diabetes which have been employed by various ethnic
groups throughout the world. One region which contains
a rich flora and fauna is Australia. However, Australian
Aboriginal plants have not been evaluated for their use in
the treatment diabetes. Therefore, in this work, the well-
characterized 3T3-L1 model was used to investigate the
role of selected Australian Aboriginal and Indian Ayurvedic
plant extracts for their anti-diabetic mechanisms and ability
to inhibit lipid accumulation.
As all these plant extracts were previously screened for
enzyme inhibition and antioxidant activity [16]. Therefore,
the aim of this follow-up study was to further evaluate the
anti-diabetic mechanisms of ethanolic extracts of 12 trad-
itional medicinal plants by glucose uptake in 3T3-L1
mouse pre-adipocytes and assessing inhibition of lipid ac-
cumulation in 3T3-L1 mouse pre-adipocytes. In addition,
cytotoxicity against MDCK cells, 3T3-L1 cells and human
cancer cell lines (cervical carcinoma HeLa cells and lung
adenocarcinoma A549 cells) was evaluated by establishing
the cytotoxic concentrations of the extracts using MTTas-
says. The Australian Aboriginal plants were selected on
the basis of availability and their known medicinal activ-
ities. The Indian Ayurvedic plants were selected according
to their reported anti-diabetic potential [17]. These plants
were known to possess anti-diabetic action and but not all
plants had been screened using the cell-based assays used
in this study. The ethno-botanical uses of the plants have
been reported earlier [16].
Methods
Dulbecco’s modified Eagle medium (DMEM), Dulbecco’s
Modified Eagle Medium/Ham’s nutrient mixture F12
(DMEM/F12), fetal bovine serum (FBS), insulin, 2-[N-(7-
Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose
(2-NBDG), trypsin/EDTA and penicillin-streptomycin were
purchased from Invitrogen Australia. Bovine serum
albumin (BSA), 3-isobutyl-1-methylxanthine (IBMX),
dexamethasone, 3-(4, 5 dimethylthiazol- 2-yl)-2, 5 di-
phenyltetrazolium bromide (MTT), d-biotin, rosiglitazone
and Oil Red O were obtained from Sigma-Aldrich,
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(MDCK) cell line was procured from the American Type
Cell Culture (ATCC). A549, HeLa and 3T3-L1 cells were
provided by Monash University, Victoria, Australia. The
cells were routinely passaged as described below.
Plant extracts
Seven Australian Aboriginal medicinal plant extracts
were provided by The University of South Australia,
Adelaide, Australia. Powdered extracts of five Indian
Ayurvedic plants were provided by Promed Research
Centre, Gurgaon, India. Tables 1 and 2 shows the list of
plants used in this study. Preparation of ethanolic plant
extracts, voucher numbers and ethno botanical informa-
tion have previously been described by our research
group [16].
Passaging of cell lines
Cells were routinely cultivated as monolayers in dispos-
able 25 cm2 flasks (Corning) in DMEM supplemented
with 10% (v/v) FBS, 1% (v/v), penicillin-streptomycin
(10,000 U/ml penicillin and 10,000 μg/ml streptomycin
in 0.85% saline) and passaged when 70-80% confluent.
The medium was aspirated from the confluent cells
using a sterile pipette and cells were washed with ap-
proximately 5 mL sterile 1X PBS solution, which was
subsequently aspirated. Trypsin/EDTA solution (2.5 mL)
was added to the flask to cover the cell monolayer and
the flask was incubated at 37°C for 3 minutes to allow the
cells to detach. Fresh medium (3 mL) was used to re-
suspend the detached cells and neutralize the action of
trypsin. The cell suspension was centrifuged at 200 g for
5 min at 20°C. The supernatant was discarded and cell
pellet was re-suspended in 5 ml of fresh medium. Cell
counts were carried by the trypan blue dye exclusion
method. Cells were seeded at a density of 1.5 × 105/flask
and incubated at 37°C in 5% CO2 atmosphere.
Cytotoxicity assay
All the four cell lines, 3T3-L1 pre-adipocyte, A549, HeLa
and MDCK used in this assay, were capable of attach-
ment to form a homogeneous monolayer on plasticTable 1 Australian Aboriginal plants
Plant name Codes used Com
Acacia kempeana F. Muell. AK Witch
Acacia. tetragonophylla F. Muell. AT Dead
Acacia ligulata Cunn. ex Benth. AL Umb
Beyeria leschenaultii (DC.) Baillon BL Turp
Euphorbia drummondii Boiss. ED Caus
Santalum lanceolatum R. Br. SL North
Santalum spicatum (R. Br.) A. DC. SS Austrsubstratum of culture wells, which is ideal for determin-
ing cytotoxicity was determined by the MTT (3-(4, 5
dimethylthiazol- 2-yl)-2, 5 diphenyltetrazolium bromide)
method test. The MTT test is a simple bioassay used for
the primary screening of crude plant extracts [18]. For
each cell line, there was a linear relationship between
cell number and absorbance; measured at 540 nm in both
control and drug-treated wells. After 72 h of treatment,
the IC50 of the plant extracts was determined. The cells
were exposed to 100 μl of each test solution {containing
various concentrations of plant extracts (1 – 500 μg/ml)
or vincristine (0.001 – 200 μg/ml)} and incubated for a
further 72 hours at 37°C. The test solutions were then
removed and the cells were washed in 1X PBS and 50 μl
of medium was added into each well. Then, 5 μl of MTT
solution (5 mg/ml PBS) was placed into each well and incu-
bated at 37°C. After 4 hours, 25 μl of cells were removed,
50 μl DMSO was added and the mixture incubated at 37°C
for 10 min. The absorbance at 540 nm was measured using
a microplate reader (Bio-Rad Laboratories).
Adipocyte differentiation of 3T3-L1 cells
3T3-L1 cells (ATCC; CL-173) represent a subclone of
the 3T3 cells which is able to undergo adipocyte differ-
entiation. Cells were cultured and differentiated as de-
scribed previously [19,20], with minor amendments.
3T3-L1 cells at passage 9 or 10 were seeded in 96-well
plates (5 × 103 cells/well) for Oil Red O staining and glu-
cose uptake measurements using DMEM/F12 medium
with 10% FBS. DMEM/F12 is a serum free medium
which is supplemented with a defined combination of
nutrients, growth factors and hormones to culture a variety
of cells. Two days after reaching confluence, the medium
was changed to differentiation medium (DMEM/F12 + 2%
FBS containing 10 μg/mL insulin, 0.5 mM (IBMX) 3-
isobutyl-1-methylxanthine and 1.0 μM dexamethasone).
3T3-L1 cells when treated with a combination of dexa-
methasone, isobutylmethylxanthine (IBMX) and insulin
adopt a rounded phenotype and within 5 days begin to ac-
cumulate lipids intracellularly in the form of lipid droplets
[21]. Cells remained in the differentiation medium for four
days with media replenished every 48 hours. Thereafter,mon name Family Part used
etty Bush Mimosaceae Leaves
finish Mimosaceae Stem
rella bush Mimosaceae Leaves
entine bush Euphorbiaceae Leaves and stem
tic weed Euphorbiaceae Whole plant
ern sandalwood Santalaceae Leaves
alian sandalwood Santalaceae Leaves









AP Kalmegh Acanthaceae Herb
Bacopa monnieri BM Brahmi Scrophulariaceae Herb
Curculigo
orchioides Gaertn.
CO Kali musli Amaryllidaceae Rhizomes
Mucuna pruriens Linn. MP Konch Fabaceae Seeds
Pterocarpus
marsupium Roxb.
PM Vijayasaar Fabaceae Wood
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FBS in which cells remained for the respective experiments.
Glucose uptake measurements
At day 9 of differentiation, adipocytes were incubated
for 24 hours with the respective test solutions. Ethanol
was used as a negative control whereas 10 μM rosiglita-
zone was used as a positive control. Next day, the cells
were rinsed with 1X PBS and incubated for 60 min at
37°C with exclusion of light in DMEM containing
80 μM of the fluorescent glucose analogue, 2-NBDG,
again in the presence of the extracts for basal glucose
uptake measurement. As a second positive control, cells
were treated with 100 nM insulin during the 2-NBDG
incubation to measure the insulin-stimulated glucose
uptake. The reaction of 2-NBDG uptake was terminated
by washing the cells with pre-cooled 1X PBS. The
remaining fluorescence activity in the cells was mea-
sured by using fluorescence microplate reader (POLAR-
Star Omega, BMG Labtech, Germany) at an excitation
wavelength of 485 nm and an emission wavelength of
535 nm. Fluorescence activity in the absence of 2-NBDG
was subtracted from all values [20].
Lipid accumulation inhibition assay and Oil Red O
staining of intracellular triglycerides
Lipid accumulation inhibition assay was carried out as
per standard protocols with minor amendments [22].
3T3-L1 cells were differentiated into adipocytes as de-
scribed above. To quantify the effect of plant extracts on
lipid accumulation in 3T3-L1 cells, the cells were treated
with fresh plant extracts in DMEM supplemented with
2% FBS every alternate day from day 2 till day 10 of
differentiation [23]. On day 10 of differentiation, the
medium was removed and the cells treated with and
without plant extracts were washed with 1X PBS and fixed
with 10% formalin for 30 minutes. Cells were rinsed with
deionized water and then incubated with Oil Red O solu-
tion (0.25% w/v in 60% isopropanol) for 1 hour at room
temperature. Finally, the dye retained in the 3T3-L1 cells
was eluted with isopropanol and quantified by measuringthe optical absorbance at 540 nm. Cells were also imaged
under a light microscope [24].Statistical analysis
All samples were analysed in triplicates. Data are pre-
sented as mean ± standard error mean (SEM). For the
final evaluation of the glucose uptake assay, fluorescence
activities measured for the negative control (solvent
ethanol) were set to 100% and values for test extracts
and positive controls were calculated accordingly. In the
case of lipid inhibition assays, cells treated with inducers
were set to 100% and values for tested extracts were
calculated accordingly. Differences were evaluated by
one-way analysis of variance (ANOVA) test completed
by a Bonferroni’s multicomparison test. Differences were
considered significant at p < 0.001. The concentration
giving 50% inhibition (IC50) was calculated by non-linear
regression with the use of GraphPad Prism Version 5.0
for Windows (GraphPad Software, San Diego, CA, USA)
(www.graphpad.com). The dose–response curve was
obtained by plotting the percentage inhibition versus
concentration [25].Results
Cytotoxicity studies
This study examined the cytotoxicity and anti-tumour ac-
tivity of Australian Aboriginal and Indian Ayurvedic plant
extracts. The ethanolic extracts were tested for cytotoxic
effects against A549, HeLa, 3T3-L1 and MDCK cells. The
cytotoxicity and selectivity of the Australian Aboriginal
plant extracts against the selected cancerous cell lines are
summarized in Table 3. According to the standard
National Cancer Institute (NCI) criteria, crude extracts
possessing an IC50 of <30 μg/ml are considered active
against the tested cancer cells [26]. Of the seven extracts
tested, only two extracts, AK and AT, showed activity ac-
cording to NCI criteria with IC50 of 13.73 ± 1.51 μg/ml
and 27.00 ± 14.28 μg/ml, respectively, against HeLa cells.
Vincristine, a chemotherapeutic drug used for some can-
cer types, had cytotoxic effects on MDCK, A549 and HeLa
with values of 145.83 μg/ml, 0.6 μg/ml and 0.39 μg/ml,
respectively. The five Indian Ayurvedic plant extracts were
also tested against selected leukemic cell lines. None of
the extracts showed promising effects (Table 4) against the
cells used in this assay.
The Australian Aboriginal plant extracts showed IC50
values in the in range of 158.81 – 386.95 μg/ml and
Indian Ayurvedic plant extracts showed IC50 values in
in range of 171.45 – 394.03 μg/ml against 3T3-L1 pre-
adipocytes cells. Thus, two concentrations, 10 and
100 μg/ml, were selected for evaluating the effects of
the extracts on adipogenesis and glucose uptake.
Table 3 IC50 values (μg/ml) of Australian Aboriginal extracts on two cancer cell lines and the non-cancerous MDCK and
3T3-L1 cell lines
Australian Aboriginal plant extracts/Control Cell lines
3T3-L1 pre adipocytes MDCK A549 HeLa
Vincristine Not determined 145.83 ± 5.20 0.6 ± 0.02 0.039 ± 0.01
AK 202.36 ± 21.44 550.03 ± 36.20 75.17 ± 6.25 13.73 ± 1.51*
AL 240.70 ± 65.22 398.51 ± 31.26 298.6 ± 44.45 110.61 ± 35.82
AT 306.46 ± 65.56 567.38 ± 52.59 210.85 ± 30.82 27.00 ± 14.28*
BL 386.95 ± 56.32 331.33 ± 30.90 84.08 ± 24.37 229.11 ± 40.57
ED 256.34 ± 59.53 460.25 ± 20.96 91.26 ± 19.84 142.50 ± 29.27
SL 173.14 ± 24.86 406 ± 24.31 162.95 ± 27.34 186.66 ± 62.21
SS 158.81 ± 25.53 283.66 ± 12.64 112.28 ± 13.28 110.11 ± 11.91
Data are expressed as mean ± SEM of independent experiment (n = 3). *denotes IC50 less than 30 μg/ml which is considered as an active extract against cancer cells.
Gulati et al. BMC Complementary and Alternative Medicine  (2015) 15:8 Page 5 of 11Glucose uptake assay
The seven Australian Aboriginal and five Indian
Ayurvedic plant extracts were tested at 10 and 100 μg/ml
concentrations to assess their impact on basal and insulin-
stimulated glucose uptake into differentiated 3T3-L1
adipocytes. After incubation for 28 hours, the Australian
Aboriginal (Figure 1) and Indian Ayurvedic plant extracts
(Figure 2) failed to enhance basal and insulin-stimulated
glucose uptake at concentration of 10 μg/ml. However,
when the same extracts were tested at 100 μg/ml, it was
observed that AK, AT and SS moderately enhanced basal
glucose uptake by 19, 19 and 16%, respectively, as com-
pared to the ethanol control (Figure 3). In contrast, rosigli-
tazone enhanced basal glucose uptake by nearly 43% as
compared to control. Of the Indian Ayurvedic plant ex-
tracts tested at 100 μg/ml, only CO was able to enhance
basal glucose uptake by nearly 19% as compared to control
(Figure 4).
AK and SS were able to enhance insulin-stimulated
glucose uptake by 45 and 47% at 100 μg/ml, respectively,
whereas, the enhancement approached 65% for rosiglita-
zone (Figure 3) and AT enhanced glucose uptake in the
presence of insulin by 34% which was approximately halfTable 4 IC50 values (μg/ml) of Indian Ayurvedic plant extracts
Indian Ayurvedic plant extracts/control
3T3-L1 pre-adipocytes
Vincristine Not determined
CO 214.73 ± 42.89
MP 256.34 ± 59.53
PM 171.45 ± 17.06
AP 352.18 ± 41.27
BM 394.03 ± 25.95
Data are expressed as mean ± SEM of independent experiment (n = 3).that of rosiglitazone (Figure 3). CO was able to enhance
glucose uptake by 48% in the presence of insulin (Figure 4).
Inhibition of lipid accumulation in 3T3-L1 cells
Adipocyte differentiation of 3T3-L1 cells is a highly-
controlled process that can be induced under a hormonal
cocktail of insulin, dexamethasone and IBMX [27]. Intra-
cellular lipid accumulation is commonly monitored as a
general marker to indicate the extent of adipogenesis in
3T3-L1 cells [7]. 3T3-L1 pre-adipocytes were differentiated
in the presence of the Australian Aboriginal and Indian
Ayurvedic plants extracts for 8 days. Figure 5 shows reduc-
tion in lipid accumulation in adipocytes treated with se-
lected extracts. Three Australian plant extracts, AT, BL and
ED, were found to significantly reduce lipid accumulation
in 3T3-L1 adipocytes, suggesting anti-obesity activity. AT
was able to significantly reduce lipid accumulation by 51
and 82% at 10 and 100 μg/ml, respectively (Figure 6). Lipid
accumulation was reduced by 34 and 35% in presence of
10 μg/ml BL and ED, respectively, and was further
reduced by 74 and 65%, respectively, with same extracts at
100 μg/ml (Figure 6). Indian Ayurvedic plants tested failed
to reduce lipid accumulation at 10 μg/ml but CO, PM andon two cancer cell lines, MDCK and 3T3-L1 cell line
Cell lines
MDCK A549 HeLa
145.83 ± 5.20 0.6 ± 0.02 0.039 ± 0.01
403.28 ± 12.64 457.6 ± 65.93 287.61 ± 42.86
441.33 ± 59.12 301.73 ± 48.71 397.41 ± 87.83
491.95 ± 35.80 416.15 ± 108.93 380.73 ± 72.88
449.55 ± 23.13 351.31 ± 59.06 487.86 ± 47.64
540.3 ± 37.66 320.36 ± 22.08 366.05 ± 37.63
Figure 2 Effect of Indian Ayurvedic plant extracts at 10 μg/ml
on basal and insulin-stimulated glucose uptake in 3T3-L1
adipocytes. Cells were treated with the individual extract for
24 hours followed by incubation for 60 min in serum and glucose-free
medium containing 80 μM 2-NBDG. Ethanol was used as a negative
control, while rosiglitazone and insulin were used as positive controls.
Cells received insulin only during 2-NBDG uptake. After incubation,
fluorescence activity remaining in the cells was measured by a
fluorescence microplate reader. Fluorescence activity in the absence of
2-NBDG was subtracted from all values. Data shown are mean ± SD of
at least three independent experiments performed in triplicates.
Significance against ethanol control (=100%): ***p < 0.001. Significance
against ethanol + 100 nM insulin control: +++ p < 0.001.
Figure 3 Effect of Australian Aboriginal plant extracts at
100 μg/ml on basal and insulin-stimulated glucose uptake in
3T3-L1 adipocytes. Cells were treated with individual extracts for
24 hours followed by incubation for 60 min in serum and glucose-free
medium containing 80 μM 2-NBDG. Ethanol was used as a negative
control, while rosiglitazone and insulin were used as positive controls.
Cells received insulin only during 2-NBDG uptake. After incubation,
fluorescence activity remaining in the cells was measured by a
fluorescence microplate reader. Fluorescence activity in the absence of
2-NBDG was subtracted from all values. Data shown are mean ± SD of
at least three independent experiments performed in triplicates.
Significance against ethanol control (=100%): **p < 0.01, ***p < 0.001.
Significance against ethanol + 100 nM insulin control: + p < 0.05, ++
p < 0.01, +++ p < 0.001.
Figure 1 Effect of Australian Aboriginal plant extracts at 10 μg/ml
on basal and insulin-stimulated glucose uptake in 3T3-L1
adipocytes. Cells were treated with individual extracts for 24 hours
followed by incubation for 60 min in serum and glucose-free medium
containing 80 μM 2-NBDG. Ethanol was used as a negative control, while
rosiglitazone and insulin were used as positive controls. Cells received
insulin only during 2-NBDG uptake. After incubation, fluorescence activity
remaining in the cells was measured by a fluorescence microplate reader.
Fluorescence activity in the absence of 2-NBDG was subtracted from all
values. Data shown are mean ± SD of at least three independent
experiments performed in triplicates. Significance against ethanol control
(=100%): ***p < 0.001. Significance against ethanol + 100 nM insulin
control: +++ p< 0.001.
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100 μg/ml (Figure 7).
Discussion
Plants have played an important role as a source of ef-
fective anti-cancer agents, and it is important to note
that over 60% of the currently used anti-cancer agents
are derived from natural sources, including plants, mar-
ine organisms and micro-organisms. The search for anti-
cancer agents from plant sources started in the 1950s
with the discovery of the alkaloids vinblastine and vin-
cristine from Vinca rosea and the isolation of cytotoxic
podophyllotoxins from Podophyllum [28]. The phyto-
chemicals present in plants possess strong antioxidant
activities that may prevent and cure cancer by protecting
healthy cells from damage caused by the highly reactive
oxygen species known as ‘free radicals’ [29]. Thus, con-
suming a diet rich in antioxidant plant foods will provide
a milieu of phytochemicals that possess health protective
effects, provide therapeutic actions to all cells with low
cytotoxicity and are beneficial in producing nutrient
repletion to immune-compromised people [30]. Strong
and consistent epidemiological evidence also indicates
Figure 4 Effect of Indian Ayurvedic plant extracts at 100 μg/ml
on basal and insulin-stimulated glucose uptake in 3T3-L1
adipocytes. Cells were treated with the individual extract for 24 hours
followed by incubation for 60 min in serum and glucose-free medium
containing 80 μM 2-NBDG. Ethanol was used as a negative control,
while rosiglitazone and insulin were used as positive controls. Cells
received insulin only during 2-NBDG uptake. After incubation,
fluorescence activity remaining in the cells was measured by a
fluorescence microplate reader. Fluorescence activity in the
absence of 2-NBDG was subtracted from all values. Data shown are
mean ± SD of at least three independent experiments performed in
triplicates. Significance against ethanol control (=100%): *p < 0.05,
**p < 0.01, ***p < 0.001. Significance against ethanol + 100 nM
insulin control: ++ p < 0.01, +++ p < 0.001.
Figure 5 Effect of AT (B) and CO (C) extracts on fat droplet formation
differentiated with 100 μg/mL of AT and CO extracts treatment for 8 days
examined using a light microscope. Scale bar is 50 μm.
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risk of many cancers [31]. Also, many studies have sug-
gested that free radicals induce oxidative stress which
leads to several disorders such as cataract, diabetes,
obesity, ageing and Alzheimer’s [32].
It has been estimated that 275 Australians develop dia-
betes every day. The 2005 Australian AusDiab Follow-up
Study (Australian Diabetes, Obesity and Lifestyle Study)
showed that 1.7 million Australians have diabetes but up
to half of the cases of type 2 diabetes remain undiag-
nosed and it is estimated that by 2033 nearly 3.5 million
Australians will have type 2 diabetes [33]. Therefore, there
is a great need to develop new drugs for diabetes. Part of
this drug discovery research effort will be to identify plant
species that can potentially be applied in the management
of type 2 diabetes and related complications of weight gain,
hypertension and immune-suppression. Australia is one of
the mega diverse countries in the world and Australian
medicinal plants are untapped source of novel chemical
scaffolds and hence there is a great need to explore Australian
Aboriginal plants [34].
In the present study, plants previously shown to dis-
play good antioxidant activity [16] were assessed for their
cytotoxicity against cancerous (HeLa and A549) and non-
cancerous (MDCK, normal epithelium and 3T3-L1 pre-
adipocytes) cell lines. The cells were exposed to the extracts
and the viability of cells was measured and expressed inin 3T3-L1 cells as compared to control (A). Pre-adipocytes were
after 72 hours of exposure, then stained with Oil Red O dye and
Figure 6 Effect of Australian Aboriginal plant extracts on Oil
Red O staining in cultured 3T3-L1 adipocytes. (A) Effect of 10
μg/ml extracts and (B) Effect of 100 μg/ml extracts on fat droplet
formation in 3T3-L1 cells. Values are expressed as mean ± standard
deviation of at least three independent experiments. Values are
mean ± SE (n = 3), significance against control (without plant
extract) (=100%): ***p < 0.001 and *p < 0.05.
Figure 7 Effect of Indian Ayurvedic plant extracts on Oil Red O
staining in cultured 3T3-L1 adipocytes. (A) Effect of 10 μg/ml
extracts and (B) Effect of 100 μg/ml extracts on fat droplet formation in
3T3-L1 cells. Values are expressed as mean ± standard deviation of at
least three independent experiments. Values are mean ± SE (n = 3),
significance against control (without plant extracts) (=100%): * p < 0.05.
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comparison with control cells.
The results of cytotoxicity testing of Australian Abori-
ginal and Indian Ayurvedic plant extracts (Tables 3 and
4) were assessed according to the US NCI plant screen-
ing program, where a crude extract is generally consid-
ered to have in vitro cytotoxic activity if the IC50 value
is <30 μg/ml. Among all the plant extracts screened
here, two extracts, AK and AT, showed particularly po-
tent activity with IC50 values of 13.73 μg/ml and
27.00 μg/ml, respectively, against HeLa cells. Other
extracts showed moderate activity. None of the Indian
Ayurvedic plant extracts investigated in the present study
are likely candidates for anti-cancer drug development as
all showed IC50 values of >200 μg/ml against HeLa and
A549 cells. None of the Australian Aboriginal plantextracts had IC50 values of <30 μg/ml against A549 cells,
AK, BL, ED, SS and SL had IC50 values of <200 μg/ml,
thus they have moderate anti-cancer activity. However,
only two cell lines were tested in this study and further
testing against other cancer cells may reveal additional
anti-cancer activity.
Based on the IC50 of the plant extracts, they can be
divided into three groups [26]:
(1) Those with IC50 values of <30 μg/ml can be
considered as potential candidates for further
development as cancer therapeutic agents;
(2) Those with IC50 values between 30 and 200 μg/ml
have moderate potential to be developed into cancer
therapeutic agents, and;
(3) Those with IC50 > 200 μg/ml are unlikely candidates
for development into cancer therapeutic agents.
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ity of phytochemicals is due to their antioxidant com-
pounds such as vitamins, minerals, polyphenols, flavonoid,
terpenoids, lignins, xanthones and polysaccharides [35].
The use of natural products as medicinal agents has a long
history that began with folk medicine and has been incor-
porated into modern medicine [36].
An important observation was that the activity against
HeLa cells exhibited by extracts AK and AT was specific
as no cytotoxicity was observed against the non-cancer
cell line, MDCK. Therefore, these extracts may be prom-
ising candidates for the development of chemotherapeu-
tic agents targeting cervical cancer with minimal side
effects against normal cells.
The well-characterized murine pre-adipose 3T3-L1
cell line was used to investigate the mechanisms of ac-
tion by which plant extracts exert their anti-diabetic ef-
fects. Since obesity is a side effect of some anti-diabetic
drugs, therefore, the effect of plants on adipogenesis
was also evaluated. The impact of plant extracts on
basal and insulin-stimulated glucose uptake into 3T3-
L1 adipocytes was examined, using the non-radioactive
method of measuring 2-NBDG uptake. Of the seven
Australian Aboriginal plant extracts tested, six were able
to enhance insulin-stimulated glucose uptake at a concen-
tration of 100 μg/ml. In contrast, only AK, AT and SS
were able to enhance basal glucose uptake. It is well
known that thiazolidinediones have beneficial effects on
hyperglycemia in type 2 diabetes, but the molecular mech-
anism is still to be elucidated. These drugs stimulate glu-
cose uptake either by enhancing synthesis of the insulin
independent (basal) glucose transporter GLUT-1 or by
increasing expression or translocation of the insulin-
dependent/sensitive glucose transporter GLUT-4 [20,37].
The extracts can also be tested for their effect on pro-
tein–tyrosine phosphatase 1B (PTP1B), a cytosolic enzyme,
that not only increase cellular response to insulin, but also
elevates leptin signalling and are therefore, a promising
strategy for the treatment of diabetes mellitus and obesity
[38]. Flavonoids such as epicatechin (EC) constitute an
important part of the human diet, and it can be found in
green tea, grapes and especially in cocoa. EC has been re-
ported to have anticancer activity [39] and its anti-diabetic
potential can be attributed to improved insulin sensitivity
[40]. Therefore, the promising findings of AT and AK ex-
tracts could be attributed to the presence of flavonoid com-
pounds, like EC, but this needs to be validated though
biochemical and HPLC-based assays. GLUT-2 transporters
are known to assist in diffusion of glucose across the
plasma membrane of hepatocytes and maintaining equilib-
rium between intracellular and extracellular glucose [41].
Therefore, extracts can be tested for their potential activity
against GLUT-2 transporters in the presence of high
glucose challenge in HepG2 cultured cells [42].Phosphotyrosine (PY20) elevates upon phosphorylation
of the insulin receptor and its substrate during the insulin
signaling pathway for the uptake of extracellular glucose
[43]. It would be useful to determine if the Australian
Aboriginal plants are able to modulate PY20 expression as
an increase in PY20 results in enhanced insulin binding
and insulin sensitivity. Insulin-like growth factor 1 recep-
tor (IGF-1R) is a potent activator of the phosphatidyl in-
ositol 3 kinase (PI3K)-Akt signalling pathway and it is also
an inhibitor of apoptosis or programmed cell death [44].
Hence, AT and AK extracts should be investigated further
for their effect on IGF-1R and PY20 levels.
Upon the completion of adipogenesis, spindle-shaped
pre-adipocytes were transformed into round-shaped cells
that accumulated lipids and acquired the metabolic
mechanisms to facilitate glucose uptake in response to
insulin, synthesize fatty acids, accumulate triglyceride
and secrete a wide variety of hormones and cytokines
[7]. Therefore, intracellular lipid accumulation is com-
monly monitored as a general marker to indicate the ex-
tent of adipogenesis in 3T3-L1 cells [45]. The results of
this study showed that the three Australian plant ex-
tracts, AT, BL and ED, were able to significantly reduce
lipid accumulation in 3T3-L1 adipocytes when com-
pared to control, suggesting anti-obesity activity which is
a desirable property for an anti-diabetic drug. Though, it
is not clear if the reduced lipid content is due to mech-
anistic perturbation, or due to increased cytotoxicity or
reduced differentiation/proliferation due to long term
exposure of the extracts. Therefore, these plant extracts
need to be further investigated by measuring protein ex-
pression of key transcription factors like peroxisome
proliferator-activated receptor gamma (PPARγ) in both
in vitro and in vivo models. The extracts could also be
tested for their effect on Adenosine 5′-monophosphate-
activated protein kinase (AMPK) which is known to
inhibit lipogenesis [46].
A number of studies have demonstrated that natural
compounds like EGCG, genistein, esculetin, berberine,
resveratrol, guggulsterone, capsaicin, baicalein and procya-
nidins inhibited adipogenesis by inhibiting preadipocyte
proliferation, suppressing lipid accumulation and inducing
apoptosis in mature adipocytes [47]. Pterostilbene from
Pterocarpus marsupium, resveratrol from red grapes have
been reported to activate PPAR alpha and posess glucose
and lipid lowering activity [48]. Australian Aboriginal
plants which are yet to be tested for their phytochemicals
might be showing good activity against lipid accumulation
due to presence of similar compounds like genistein,
resveratrol and quercetin.
Morphological observations of cells stained with Oil
Red O, a lipid stain, showed a decrease in cellular lipid
content in cells treated with plant extracts. Among the
Indian Ayurvedic plant extracts, CO, PM and AP
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cumulation. DNA microarray analysis can also be looked
at to understand effect of plant extracts on expression of
a number of genes and long non-coding RNAs impli-
cated to play a role in the control of adipogenesis [46].
3T3-L1 cells are widely used models of adipocyte func-
tion. In vivo, excessive triglyceride accumulation by the
adipocyte has been linked to an increased risk of a var-
iety of metabolic disorders [49]. Tannins, catechins and
epicatechins are the most active antioxidant constituents
and are found to enhance the glucose uptake and inhibit
adipogenesis in differentiated adipocytes [50,51]. The
presence of phenolic compounds, tannins, alkaloids,
procyanidins and cyanogenic glycosides have been attrib-
uted to the hypoglycaemic action of various plants [6].
The antioxidant activity of the plants was evaluated
against free radicals which can damage biomolecules in
our body, cause cellular membrane peroxidation and
attract various inflammatory mediators [52]. Phenolic
compounds and flavonoids are known to have antidia-
betic, antitumor properties, antiproliferative effects and
induce apoptosis in different cancer cell lines. They are
free radical scavengers, and flavonoids in particular
inhibit invasion and metastasis [53].
Conclusions
The results of the current study showed that plants extract
AT probably exerts its anti-diabetic properties by stimulat-
ing glucose uptake in adipocytes with significant inhibition
of adipogenesis. Plant extracts AK, SS and CO were also
observed to enhance basal and insulin-stimulated glucose
uptake. BL, ED, MP and PM inhibited lipid accumulation
but should be further studied using anti-lipase activity as-
says and Western blot analysis to confirm their anti-
adipogenic effect. The ability of AT to enhance glucose
uptake in insulin-resistant adipocytes, in addition to its
anti-adipogenic effects, suggests that this extract could be
useful in the treatment of type 2 diabetes. Future studies
should address the molecular mechanisms by which these
plants and their active compounds regulate glucose uptake
by adipose and muscle tissues. To our knowledge, this is
the first study of the potential use of Australian Aboriginal
plant extracts in the management of diabetes and related
complications. The ability of existing therapies to target
various aspects of the insulin resistance syndrome induces
other metabolic abnormalities, chiefly those involved in
lipid metabolism. Therefore, glucose-lowering drugs with
minimal adipogenic activity are desirable and this study
has demonstrated but future experiments are needed to
clarify the chemical structures responsible of such bio-
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